Global Non-opioid Pain Patch Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Non-opioid Pain Patch Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
A non-opioid pain patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
Non-opioid Pain Patch report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Non-opioid Pain Patch market is projected to reach US$ 779.5 million in 2034, increasing from US$ 631.4 million in 2022, with the CAGR of 2.6% during the period of 2024 to 2034. Demand from OTC and Rx are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Non-opioid Pain Patch industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Non-opioid Pain Patch key manufacturers include Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, Teikoku Seiyaku, Sanofi, Novartis and Qizheng, etc. Hisamitsu, Mylan, Johnson & Johnson are top 3 players and held % sales share in total in 2022.
Non-opioid Pain Patch can be divided into Lidocaine Patches, Diclofenac Patches, Indomethacin Patches and Counter-Irritant Patches, etc. Lidocaine Patches is the mainstream product in the market, accounting for % sales share globally in 2022.
Non-opioid Pain Patch is widely used in various fields, such as OTC and Rx, etc. OTC provides greatest supports to the Non-opioid Pain Patch industry development. In 2022, global % sales of Non-opioid Pain Patch went into OTC filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Non-opioid Pain Patch market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
Hisamitsu
Mylan
Johnson & Johnson
Actavis
Lingrui
Teikoku Seiyaku
Sanofi
Novartis
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
BLUE-EMU
Segment by Type
Lidocaine Patches
Diclofenac Patches
Indomethacin Patches
Counter-Irritant Patches
Fentanyl Patches
Others
OTC
Rx
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Non-opioid Pain Patch market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Non-opioid Pain Patch, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Non-opioid Pain Patch industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Non-opioid Pain Patch in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Non-opioid Pain Patch introduction, etc. Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Non-opioid Pain Patch market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.![](http://localhost/mraccuracy/images/About Report.webp)
Non-opioid Pain Patch report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Non-opioid Pain Patch market is projected to reach US$ 779.5 million in 2034, increasing from US$ 631.4 million in 2022, with the CAGR of 2.6% during the period of 2024 to 2034. Demand from OTC and Rx are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Non-opioid Pain Patch industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Non-opioid Pain Patch key manufacturers include Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, Teikoku Seiyaku, Sanofi, Novartis and Qizheng, etc. Hisamitsu, Mylan, Johnson & Johnson are top 3 players and held % sales share in total in 2022.
Non-opioid Pain Patch can be divided into Lidocaine Patches, Diclofenac Patches, Indomethacin Patches and Counter-Irritant Patches, etc. Lidocaine Patches is the mainstream product in the market, accounting for % sales share globally in 2022.
Non-opioid Pain Patch is widely used in various fields, such as OTC and Rx, etc. OTC provides greatest supports to the Non-opioid Pain Patch industry development. In 2022, global % sales of Non-opioid Pain Patch went into OTC filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Non-opioid Pain Patch market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
By Company
Hisamitsu
Mylan
Johnson & Johnson
Actavis
Lingrui
Teikoku Seiyaku
Sanofi
Novartis
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
BLUE-EMU
Segment by Type
Lidocaine Patches
Diclofenac Patches
Indomethacin Patches
Counter-Irritant Patches
Fentanyl Patches
Others
Segment by Application
OTC
Rx
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Non-opioid Pain Patch market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Non-opioid Pain Patch, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Non-opioid Pain Patch industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Non-opioid Pain Patch in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Non-opioid Pain Patch introduction, etc. Non-opioid Pain Patch Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Non-opioid Pain Patch market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
![](http://localhost/mraccuracy/images/About Report.webp)